Site Editor

Soo Park, MD


Jenny H. Chang, MD, on Neoadjuvant Immunotherapy for Merkel Cell Carcinoma

Posted: Tuesday, April 16, 2024

Jenny H. Chang, MD, of the Cleveland Clinic, discusses her new treatment findings on stage III Merkel cell carcinoma and the potential for adding neoadjuvant immunotherapy to the standard regimen of surgical excision with adjuvant or definitive radiotherapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.